News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MAIN ALAN J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/01/2023 |
4
| MAIN ALAN J (EVP, Innov & Chem Sciences) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 20,946 shares
@ $2.17, valued at
$45.5k
Exercised 23,300 restricted stock units
@ $0
Exercised 8,976 restricted stock units
@ $0
Exercised 25,667 restricted stock units
@ $0 |
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| MAIN ALAN J (EVP, Innov & Chem Sciences) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 230,990 options to buy
@ $3.2, valued at
$739.2k
Granted 77,000 restricted stock units
@ $0 |
|
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2020 |
4
| MAIN ALAN J (EVP, Commercial Supply Ops) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 19,893 shares
@ $0
Paid exercise price by delivering 6,813 shares
@ $1.96, valued at
$13.4k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2018 |
4
| MAIN ALAN J (EVP, Commercial Supply Ops) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 4,962 shares
@ $8.53, valued at
$42.3k
Exercised 2,679 restricted stock units
@ $0
Exercised 5,272 restricted stock units
@ $0
Exercised 4,085 restricted stock units
@ $0
Exercised 2,497 restricted stock units
@ $0 |
|
| 02/12/2018 |
4
| MAIN ALAN J (EVP, Commercial Supply Ops) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 24,890 restricted stock units
@ $0
Granted 69,940 options to buy
@ $9.79, valued at
$684.7k
|
|
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2013 |
4
| MAIN ALAN J (EVP, Pharmaceutical Research) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Paid exercise price by delivering 12,572 shares
@ $1.98, valued at
$24.9k
Exercised 16,250 options to buy
@ $0
Exercised 17,500 options to buy
@ $0 |
|
| 02/12/2013 |
4
| MAIN ALAN J (EVP, Pharmaceutical Research) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Granted 66,000 options to buy
@ $0
Granted 264,000 options to buy
@ $2.09, valued at
$551.8k
|
|
| 03/01/2012 |
4
| MAIN ALAN J (EVP, Pharmaceutical Research) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Paid exercise price by delivering 5,907 shares
@ $1.78, valued at
$10.5k
Exercised 16,250 options to buy
@ $0 |
|
| 02/17/2012 |
4
| MAIN ALAN J (EVP, Pharmaceutical Research) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Granted 70,000 options to buy
@ $0
Granted 280,000 options to buy
@ $1.8, valued at
$504k
|
|
| 12/27/2011 |
4
| MAIN ALAN J (EVP, Pharmaceutical Research) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Exercised 44,973 options to buy
@ $1.13, valued at
$50.8k
|
|
| 02/17/2010 |
4
| MAIN ALAN J (EVP, Pharmaceutical Research) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE|
Txns:
| Paid exercise price by delivering 7,314 shares
@ $1.91, valued at
$14k
Granted 325,000 options to buy
@ $1.9, valued at
$617.5k
Granted 31,600 options to buy
@ $0 |
|
| 08/14/2009 |
4
| MAIN ALAN J (EVP, Pharmaceutical Research) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC./DE |
|
|